MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A STUDY OF CLINICAL SPECTRUM, RISK FACTORS AND OUTCOME OF DRUG-INDUCED MOVEMENT DISORDERS

    R. Anand, S. Pandey, HS. Malhotra, RK. Garg, N. Kumar, R. Uniyal, I. Rizvi (Lucknow, India)

    Objective: We aimed to characterize the spectrum of DIMDs, and the culprit agents commonly encountered in the movement disorder clinic. We also set out to…
  • 2022 International Congress

    Impact of two different rechargeable pulse generators on parkinsonian patients with deep brain stimulation

    C. Bogaert, C. Der Linden (Gent, Belgium)

    Objective: This study compared the recharging frequency and duration, perceived impact and self-management of recharging, and motor symptom suppression in fifteen PD patients who underwent…
  • 2022 International Congress

    Exploring Driving Behaviour in Patients with Functional Neurological Disorders (FND)

    TJ. Lagrand (Brisbane, Australia)

    Objective: The overarching objective of this study is to explore driving behaviour in individuals with FND phenotypes. Specifically, this research aims to enhance understanding of…
  • 2022 International Congress

    Detecting Parkinson’s Disease from body limb acceleration using machine learning and a frequency-domain analysis

    C. Cermeño-Silveira, JI. Godino-Llorente, A. Muñoz-Gonzalez, J. Perez-Sanchez, M. Gonzalez-Sanchez, F. Grandas-Perez, D. Torricelli (Madrid, Spain)

    Objective: To test whether the acceleration frequency of different body parts during gait can reveal characteristic patterns of Parkinson’s Disease (PD). The technical aim was…
  • 2022 International Congress

    Unravelling Hidden Mutations Behind the Heterozygos SYNE1 Genotype

    Y. Salamatova, L. Terpak, E. Giatour, N. Shneyder (jacksonville, USA)

    Objective: To present case series of four patients of heterozygous for SYNE1 mutation with phenotype consistent with cerebellar ataxia. Background: Recessive cerebellar ataxias are defined as disorders with autosomal recessive…
  • 2022 International Congress

    Dopaminergic modulation of express reaching responses in Parkinson’s disease

    M. Gilchrist, R. Kozak, B. Corneil, P. Macdonald (London, Canada)

    Objective: This study investigates the role of dopamine (DA) in modulation of automatic stimulus-driven responses. We investigated the effect of PD, DA medication, and instruction…
  • 2022 International Congress

    Elimination of STN stimulation-induced dyskinesias with ViM DBS

    D. Shah-Zamora, J. Karl, L. Verhagen (Chicago, USA)

    Objective: To describe effects of thalamic deep brain stimulation (DBS) on severe dyskinesias induced by subthalamic nucleus (STN) DBS in a person with Parkinson’s disease…
  • 2022 International Congress

    Activity and sleep associated with changes in glymphatic imaging-markers in Parkinson Disease patients enrolled in 3-month exercise program

    J. Elenberger, J. Eisma, K. Hett, A. Song, C. Mcknight, Y. Yan, H. Kang, M. Donahue, D. Claassen, C. Considine (Nashville, USA)

    Objective: To investigate whether intensity of activity and quality of sleep during a 3-month exercise program for patients with Parkinson Disease (PD) are associated with…
  • 2022 International Congress

    Frequency dependent interindividual variability of the deep brain stimulation effect on upper-limb bradykinesia

    P. Dorin, D. Brogle, S. Hägele-Link, M. Krüger, G. Kägi, F. Brugger (St. Gallen, Switzerland)

    Objective: To demonstrate that there are interindividual differences in the response of upper limb bradykinesia to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson’s…
  • 2022 International Congress

    Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets

    L. Adar, N. Vostokova (Rehovot, Israel)

    Objective: To determine the relative bioavailability of levodopa when administered as a subcutaneous (SC) levodopa/carbidopa (LD/CD) infusion with ND0612 versus levodopa derived from oral immediate-release…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley